Business Description
Aquestive Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US03843E1047
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.72 | |||||
Equity-to-Asset | -1.86 | |||||
Debt-to-Equity | -0.31 | |||||
Debt-to-EBITDA | 28.19 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -5.14 | |||||
Beneish M-Score | -1.58 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.4 | |||||
3-Year EPS without NRI Growth Rate | 59.8 | |||||
3-Year FCF Growth Rate | 55.5 | |||||
3-Year Book Growth Rate | -3.5 | |||||
Future 3-5Y Total Revenue Growth Rate | 18.55 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.12 | |||||
9-Day RSI | 43.44 | |||||
14-Day RSI | 45.83 | |||||
6-1 Month Momentum % | 198.57 | |||||
12-1 Month Momentum % | 226.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.24 | |||||
Quick Ratio | 1.87 | |||||
Cash Ratio | 1.3 | |||||
Days Inventory | 114.1 | |||||
Days Sales Outstanding | 40.09 | |||||
Days Payable | 182.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.6 | |||||
Shareholder Yield % | 1.27 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.82 | |||||
Operating Margin % | -29.86 | |||||
Net Margin % | -15.56 | |||||
FCF Margin % | -14.58 | |||||
ROA % | -13.47 | |||||
ROIC % | -42.29 | |||||
ROC (Joel Greenblatt) % | -1.65 | |||||
ROCE % | -0.62 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.32 | |||||
EV-to-EBIT | -2227.12 | |||||
EV-to-EBITDA | 307.12 | |||||
EV-to-Revenue | 7.18 | |||||
EV-to-Forward-Revenue | 7.26 | |||||
EV-to-FCF | -49.22 | |||||
Earnings Yield (Greenblatt) % | -0.04 | |||||
FCF Yield % | -2.01 |